SCHEMBL8489079

SCHEMBL8489079

COc1ccc(-c2nc(N)nc(-c3ccc(OC)c(OC)c3)n2)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.58
HSD17B10 Q99714 2/20 0.58
DHFR P00374 1/20 0.52
ALDH1A1 P00352 6/20 0.51
TDP1 Q9NUW8 2/20 0.51
GAA P10253 2/20 0.51
GFER P55789 2/20 0.51
MPI P34949 1/20 0.51
APOBEC3G Q9HC16 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HRH4 Q9H3N8 1/20 0.50
ADORA1 P30542 1/20 0.50
PDE4A P27815 1/20 0.48
CYP3A4 P08684 1/20 0.48
TSHR P16473 1/20 0.48
GLA P06280 1/20 0.48
MAPT P10636 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9566448 0.96 KDM4E (0.58) KDM4EHSD17B10DHFRALDH1A1TDP1
SCHEMBL7616076 0.90 ALDH1A1 (0.58) KDM4EHSD17B10ALDH1A1TDP1GAA
SCHEMBL9566413 0.82 HRH4 (0.66) KDM4EHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL5031343 0.82 RAB9A (0.57) KDM4EHSD17B10ALDH1A1GAAMEN1
SCHEMBL5066542 0.82 NPC1 (0.54) KDM4EALDH1A1GAAGFERADORA1
SCHEMBL1388381 0.79 DYRK1A (0.66) KDM4EHSD17B10DHFRALDH1A1GAA
SCHEMBL7140279 0.78 ALDH1A1 (0.59) KDM4EHSD17B10ALDH1A1TDP1GAA
SCHEMBL30610431 0.78 ALDH1A1 (0.59) KDM4EHSD17B10ALDH1A1TDP1GAA
SCHEMBL2180788 0.77 L3MBTL1 (0.53) KDM4EHSD17B10ALDH1A1TDP1GAA
SCHEMBL7708794 0.77 KDM4E (0.54) KDM4EHSD17B10ALDH1A1TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999011633-A1 TRIAZINES WITH AN ADENOSINE ANTAGONISTIC EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-03-11 WO disclosed